Patents by Inventor Jan Glinski

Jan Glinski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of purifying and identifying the presence of and levels of procyanidin oligomeric compounds
    Patent number: 9334257
    Abstract: The invention provides methods of purifying and quantifying procyanidin oligomers from cocoa-containing sources. The methods advantageously provide ways to isolate commercially useful quantities of a range of procyanidin oligomers.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: May 10, 2016
    Assignee: The Hershey Company
    Inventors: Jan Glinski, W. Jeffrey Hurst
  • METHODS OF PURIFYING AND IDENTIFYING THE PRESENCE OF AND LEVELS OF PROCYANIDIN OLIGOMERIC COMPOUNDS
    Publication number: 20150133681
    Abstract: The invention provides methods of purifying and quantifying procyanidin oligomers from cocoa-containing sources. The methods advantageously provide ways to isolate commercially useful quantities of a range of procyanidin oligomers.
    Type: Application
    Filed: November 10, 2014
    Publication date: May 14, 2015
    Inventors: Jan Glinski, W. Jeffrey Hurst
  • Use of at Least One Isoquinoline Compound of Formula I, Pharmaceutical Composition for Treating or Preventing Neurodegenerative Diseases and Method for Treating or Preventing Neurodegenerative Diseases
    Publication number: 20120302593
    Abstract: The present invention concern the use of isoquinoline alkaloid compounds of formula I in the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases, particularly Alzheimer's disease, as well as pharmaceutical composition comprising said compounds and method of treatment of neurodegenerative diseases wherein R1 is —OH or —OCH3, and X is non-existent, HCl or HBr, including their isomers,
    Type: Application
    Filed: January 19, 2011
    Publication date: November 29, 2012
    Inventors: Luiz Francisco Pianowski, Joäo Batista Calixto, Jan A. Glinski
  • NOVEL COMPOSITIONS CONTAINING ISOLATED TETRAMERIC TYPE A PROANTHOCYANADIN AND METHODS OF USE AND MANUFACTURE
    Publication number: 20100029756
    Abstract: The present invention relates to compositions containing an isolated novel tetrameric type A proanthocyanidin isomer having a formula of C60H48O24. The isomer is most preferably isolated from cinnamon (Cinnamomum spp.) and may be used in pharmaceutical compositions as anti-inflammatories, bactericides, antimicrobial formulations, or supplements for general or specific uses.
    Type: Application
    Filed: August 4, 2009
    Publication date: February 4, 2010
    Inventors: Michael S. TEMPESTA, Jan A. Glinski, K. Brian Killday
  • Method of Extraction of Catechin Type-A Proanthocyanidins
    Publication number: 20080306141
    Abstract: Catechin type-A proanthocyanidins are recovered from cinnamon bark or other sources rich in catechin type-A proanthocyanidins by extraction with a first organic solvent to provide an extract rich in catechin type-A proanthocyanidins. This extract is combined with water and the organic solvent is removed by distillation so that proanthocyanidins are transferred to the aqueous phase with the precipitation of hydrophobic materials. The aqueous extract is further purified by contact with a second organic solvent that is immiscible with water and appropriate polarity to remove reddish colored, higher polymeric proanthocyanidins from the aqueous phase. The purified aqueous extract is then subjected to evaporative concentration to produce a first solid extract. Extraction of the first solid extract with dry acetone produces an organic extract which, upon removal of the acetone, produces a solid which is enriched in catechin type-A proanthocyanidins. Purity is increased by about another 20%.
    Type: Application
    Filed: January 10, 2008
    Publication date: December 11, 2008
    Inventor: Jan Glinski
  • Hair and skin protecting compositions based on esters or ethers of betulin
    Publication number: 20060093571
    Abstract: Personal care compositions and formulations, which include conventional concentrations of known hair and skin altering components and a cosmetically acceptable amount of oil-soluble betulin and allo-betulin esters or ethers derived from betulin or allo-betulin in effective amounts are disclosed.
    Type: Application
    Filed: October 31, 2005
    Publication date: May 4, 2006
    Inventor: Jan Glinski
  • Pentacyclic triterpenes
    Patent number: 6458834
    Abstract: The present invention relates to fuingicidally effective compositions containing at least one pentacyclic triterpene compound.
    Type: Grant
    Filed: April 2, 2001
    Date of Patent: October 1, 2002
    Assignee: Micro Flo Company
    Inventors: Jan Glinski, Keith L. Branly
  • Pentacyclic triterpenes
    Patent number: 6433010
    Abstract: The present invention relates to fungicidally effective compositions containing at least one pentacyclic triterpene compound.
    Type: Grant
    Filed: April 2, 2001
    Date of Patent: August 13, 2002
    Assignee: Micro Flo Company
    Inventors: Jan Glinski, Keith L. Branly
  • Pentacyclic triterpenes
    Patent number: 6303589
    Abstract: The present invention relates to fungicidally effective compositions containing at least one pentacyclic triterpene compound.
    Type: Grant
    Filed: December 8, 1998
    Date of Patent: October 16, 2001
    Assignee: Micro Flo Company
    Inventors: Jan Glinski, Keith L. Branly
  • Pentacyclic triterpenes
    Publication number: 20010029254
    Abstract: The present invention relates to fungicidally effective compositions containing at least one pentacyclic triterpene compound.
    Type: Application
    Filed: April 2, 2001
    Publication date: October 11, 2001
    Inventors: Jan Glinski, Keith Branly
  • Pentacyclic triterpenes
    Publication number: 20010018459
    Abstract: The present invention relates to fuingicidally effective compositions containing at least one pentacyclic triterpene compound.
    Type: Application
    Filed: April 2, 2001
    Publication date: August 30, 2001
    Inventors: Jan Glinski, Keith Branly
  • Quaternary pyridinium compounds and uses therefor
    Patent number: 5290942
    Abstract: Quaternary pyridinium compounds for use as acetylcholinesterase inhibitors of the following formulas: ##STR1##
    Type: Grant
    Filed: January 19, 1993
    Date of Patent: March 1, 1994
    Assignee: Georgia Tech Research Corporation
    Inventors: James C. Powers, Sheldon W. May, Maria A. Hernandez, Steve Thornton, Jan Glinski
  • Quaternary pyridinium compounds
    Patent number: 5206371
    Abstract: Quaternary pyridinium compounds, their use in inhibiting acetylcholinesterase, their roles in the prophylaxis and treatment of organophosphate poisoning, their roles in anticholinesterase therapy and their roles as agents mimicking or opposing the actions of the natural neurotransmitter acetylcholine.
    Type: Grant
    Filed: June 2, 1992
    Date of Patent: April 27, 1993
    Assignee: Georgia Tech Research Corporation
    Inventors: James C. Powers, Sheldon W. May, Maria A. Hernandez, Steve Thornton, Jan Glinski
  • Quaternary pyridinium compounds
    Patent number: 5180831
    Abstract: Quaternary pyridinium compounds, their use in inhibiting acetylcholinesterase, their roles in the prophylaxis and treatment of organophosphate poisoning, their roles in anticholinesterase therapy and their roles as agents mimicking or opposing the actions of the natural neurotransmitter acetylcholine.
    Type: Grant
    Filed: August 10, 1990
    Date of Patent: January 19, 1993
    Assignee: Georgia Tech Research Corporation
    Inventors: James C. Powers, Sheldon W. May, Maria A. Hernandez, Steve Thornton, Jan Glinski
  • Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
    Patent number: 5157049
    Abstract: The invention involves the treatment of cancer in humans by administering water soluble derivatives of taxol. The types of cancer so treatable are those sensitive to treatment with taxol.
    Type: Grant
    Filed: October 31, 1991
    Date of Patent: October 20, 1992
    Assignee: The United States of America as represented by the Department of Health & Human Services
    Inventors: Rudiger D. Haugwitz, Leon Zalkow, Jan Glinski, Mathew Suffness, Howard M. Deutsch, Venkatachala Narayanan
  • Water soluble, antineoplastic derivatives of taxol
    Patent number: 4942184
    Abstract: Antineoplastic, water soluble, taxol derivatives and methods for preparing the same are described.
    Type: Grant
    Filed: March 7, 1988
    Date of Patent: July 17, 1990
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Rudiger D. Haugwitz, Leon Zalkow, Jan Glinski, Mathew Suffness, Howard M. Deutsch, Venkatachala Narayanan